Coelution of Other Proteins with Albumin during Size-Exclusion HPLC: Implications for Analysis of Urinary Albumin
Open Access
- 1 March 2006
- journal article
- Published by Oxford University Press (OUP) in Clinical Chemistry
- Vol. 52 (3) , 389-397
- https://doi.org/10.1373/clinchem.2005.057323
Abstract
Background: Size-exclusion HPLC has been used as an alternative to immunoassays for quantifying urinary albumin (microalbumin). Systematically higher values for the HPLC method have been proposed to result from nonimmunoreactive albumin.Keywords
This publication has 45 references indexed in Scilit:
- Characterization of Immunochemically Nonreactive Urinary AlbuminClinical Chemistry, 2004
- Which method for quantifying urinary albumin excretion gives what outcome? A comparison of immunonephelometry with HPLCKidney International, 2004
- Microalbuminuria: Definition, Detection, and Clinical SignificanceThe Journal of Clinical Hypertension, 2004
- Microalbuminuria and cardiovascular riskAmerican Journal of Hypertension, 2004
- Earlier detection of microalbuminuria in diabetic patients using a new urinary albumin assayKidney International, 2004
- Differences in urinary albumin detected by four immunoassays and high-performance liquid chromatographyClinical Biochemistry, 2003
- High prevalence of immuno-unreactive intact albumin in urine of diabetic patientsAmerican Journal of Kidney Diseases, 2003
- Microalbuminuria: Prognostic and Therapeutic Implications in Diabetes MellitusDiabetic Medicine, 1994
- Microalbuminuria Predicts Clinical Proteinuria and Early Mortality in Maturity-Onset DiabetesNew England Journal of Medicine, 1984
- MICROALBUMINURIA AS A PREDICTOR OF CLINICAL NEPHROPATHY IN INSULIN-DEPENDENT DIABETES MELLITUSThe Lancet, 1982